Global Over-the-Counter Drugs Market Size, Share, Trends, Opportunities Analysis Forecast Report 2032

Over-The-Counter Drugs Market

Over-The-Counter Drugs Market By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others), By End-Users (Specialty Clinic, Home Care, Hospital, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 229 Report Code: ZMR-5362 Published Date: Oct-2026 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 125.4 Billion USD 218.8 Billion 6.5% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. N95 Mask Market, 2016 – 2026 (USD Million)
    • 2.2. N95 Mask Market: Snapshot
  • Chapter 3. N95 Mask Market – Industry Analysis
    • 3.1. N95 Mask Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing trend of self-medication
      • 3.2.2. Growing patent expirations
    • 3.3. Restraints
      • 3.3.1. Concerns regarding improper diagnosis
      • 3.3.2. Issues related to substance abuse
    • 3.4. Opportunities
      • 3.4.1. Product innovation
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Product
      • 3.6.2. Market attractiveness analysis by Region
  • Chapter 4. N95 Mask Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global N95 Mask Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global N95 Mask Market –Product Analysis
    • 5.1. Global N95 Mask Market overview: by Product
      • 5.1.1. Global N95 Mask Market share, by Product, 2019 and 2026
    • 5.2. Cough & Flu Products
      • 5.2.1. Global N95 Mask Market by Cough & Flu Products, 2016 – 2026 (USD Million)
    • 5.3. Analgesics
      • 5.3.1. Global N95 Mask Market by Analgesics, 2016 – 2026 (USD Million)
    • 5.4. Culd
      • 5.4.1. Global N95 Mask Market by Culd, 2016 – 2026 (USD Million)
    • 5.5. Weight Loss Products
      • 5.5.1. Global N95 Mask Market by Weight Loss Products, 2016 – 2026 (USD Million)
    • 5.6. Mineral and Vitamin Supplements
      • 5.6.1. Global N95 Mask Market by Mineral and Vitamin Supplements, 2016 – 2026 (USD Million)
    • 5.7. Gastrointestinal Products
      • 5.7.1. Global N95 Mask Market by Gastrointestinal Products, 2016 – 2026 (USD Million)
    • 5.8. Ophthalmic Products
      • 5.8.1. Global N95 Mask Market by Ophthalmic Products, 2016 – 2026 (USD Million)
    • 5.9. Skin Products
      • 5.9.1. Global N95 Mask Market by Skin Products, 2016 – 2026 (USD Million)
    • 5.10. Others
      • 5.10.1. Global N95 Mask Market by Others, 2016 – 2026 (USD Million)
  • Chapter 6. Global N95 Mask Market - Regional Analysis
    • 6.1. Global N95 Mask Market overview: by Region
      • 6.1.1. Global N95 Mask Market share, by Region, 2019 and 2026
    • 6.2. North America
      • 6.2.1. North America N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.2.2. North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.2.3. U.S.
        • 6.2.3.1. U.S. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.3.2. Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.3. UK
        • 6.3.3.1. U.K. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.4.2. Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.5.2. Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa N95 Mask Market, 2016 – 2026 (USD Million)
      • 6.6.2. The Middle East and Africa N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. GlaxoSmithKline (GSK)
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Usage Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Sun Pharmaceutical Industries Ltd.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Usage Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Bayer HealthCare
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Usage Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Johnson & Johnson
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Usage Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Pfizer
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Usage Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Sanofi
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Usage Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Alkem Laboratories Limited
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Usage Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Glenmark Pharmaceuticals Ltd.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Usage Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Cipla, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Usage Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Takeda
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Usage Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Teva Pharmaceutical Industries Ltd.
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Usage Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. Reckitt Benckiser Group Plc
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Usage Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Innovus Pharmaceutical Inc.
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Usage Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Piramal
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Usage Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. Dr. Reddy's Laboratories
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Usage Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global N95 Mask Market, 2016 – 2026 (USD Million)
4. Porter’s Five Forces Analysis
5. Global N95 Mask Market attractiveness, by Product
6. Global N95 Mask Market attractiveness, by Region
7. Global N95 Mask Market share, by Product, 2019 and 2026
8.  Global N95 Mask Market by Cough & Flu Products, 2016 – 2026 (USD Million)
9.  Global N95 Mask Market by Analgesics, 2016 – 2026 (USD Million)
10.  Global N95 Mask Market by Cold, 2016 – 2026 (USD Million)
11.  Global N95 Mask Market by Weight Loss Products, 2016 – 2026 (USD Million)
12.  Global N95 Mask Market by Mineral and Vitamin Supplements, 2016 – 2026 (USD Million)
13.  Global N95 Mask Market by Gastrointestinal Products, 2016 – 2026 (USD Million)
14.  Global N95 Mask Market by Gastrointestinal Products, 2016 – 2026 (USD Million)
15.  Global N95 Mask Market by Skin Products, 2016 – 2026 (USD Million)
16.  Global N95 Mask Market by Others, 2016 – 2026 (USD Million)
17.  Global N95 Mask Market share, by Region, 2019 and 2026
18.  North America N95 Mask Market, 2016 – 2026 (USD Million)
19.  Europe N95 Mask Market, 2016 – 2026 (USD Million)
20.  Asia Pacific N95 Mask Market, 2016 – 2026 (USD Million)
21.  Latin America N95 Mask Market, 2016 – 2026 (USD Million)
22.  The Middle East and Africa N95 Mask Market, 2016 – 2026 (USD Million)


Table Of Tables

List of Tables

1. Global N95 Mask Market: snapshot
2. Drivers of the N95 Mask Market: impact analysis
3. Restraints of the N95 Mask Market: impact analysis
4. North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
5. U.S. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
6. Rest of North America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
7. Europe N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
8. U.K. N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
9. France N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
10. Germany N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
11. Rest of Europe N95 Mask revenue, by Product, 2016 – 2026 (USD Million)
12. Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
13. China N95 Mask revenue, by Product, 2016 – 2026 (USD Million)
14. Japan N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
15. India N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
16. Rest of Asia Pacific N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
17. Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
18. Brazil N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
19. Rest of Latin America N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
20. The Middle East and Africa N95 Mask Market revenue, by Product, 2016 – 2026 (USD Million)
 

Methodology

FrequentlyAsked Questions

Over-the-counter drugs are medicines that can be purchased without a doctor’s prescription. They are used to relieve common symptoms or to help prevent or manage certain conditions and are typically regulated to ensure safety and effectiveness when used without direct medical supervision.

Key growth drivers include the increasing trend of self-medication, patent expirations, cost savings in developing regions, prescription-to-OTC switches, convenience of purchase, demand from emerging countries, favorable regulatory structures, and rising consumer awareness through online information.

The global over-the-counter drugs market was valued at approximately USD 125.4 billion in 2023 and is projected to reach around USD 218.8 billion by 2032.

The global over-the-counter drugs market is expected to expand at a compound annual growth rate of approximately 6.5% between 2024 and 2032.

North America will be the foremost region during the estimate period. Europe will be the second largest market, and Asia Pacific will grow at a speedy rate.

Major players include GlaxoSmithKline (GSK), Sun Pharmaceutical Industries Ltd., Bayer HealthCare, Johnson & Johnson, Pfizer, Sanofi, Alkem Laboratories Limited, Glenmark Pharmaceuticals Ltd., Cipla, Inc., Takeda, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc, Innovus Pharmaceutical Inc., Piramal, and Dr. Reddy's Laboratories.

The report provides comprehensive analysis of market size, growth drivers, restraints, opportunities, segmentation by product and related channels, regional dynamics, competitive landscape, and future outlook for the period 2024-2032.

HappyClients